| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/1999 | CA2305179A1 Oral administration preparation |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2304951A1 Active agent transport systems |
| 04/08/1999 | CA2304813A1 Nucleic acid catalysts with endonuclease activity |
| 04/08/1999 | CA2304763A1 A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof |
| 04/08/1999 | CA2304719A1 Modulation of nitric oxide production |
| 04/08/1999 | CA2304656A1 Processes and intermediates useful to make antifolates |
| 04/08/1999 | CA2304594A1 Amorphous paroxetine composition |
| 04/08/1999 | CA2304516A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 04/08/1999 | CA2304482A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | CA2304472A1 Method for treating sexual dysfunction |
| 04/08/1999 | CA2304058A1 Cyclic phosphites and phosphates |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/08/1999 | CA2303930A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
| 04/08/1999 | CA2303832A1 Thrombin inhibitors |
| 04/08/1999 | CA2303830A1 Novel angiogenesis inhibitors |
| 04/08/1999 | CA2302027A1 Condensed benzothiopyranic compounds |
| 04/08/1999 | CA2302025A1 Tricyclic 3-oxo-propanenitrile compounds |
| 04/08/1999 | CA2301869A1 Sustained release tablet formulation to treat parkinson disease |
| 04/08/1999 | CA2273028A1 Stable compositions containing biologically active components |
| 04/08/1999 | CA2246626A1 Rabies recombinant adenovirus |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/08/1999 | CA2213680A1 Nucleotide sequences and protein sequences |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906958A2 Staphylococcus peptidyl-tRNA hydrolase (Pth) |
| 04/07/1999 | EP0906957A2 Lgt polypeptide |
| 04/07/1999 | EP0906956A2 MurD from Streptococcus pneumoniae |
| 04/07/1999 | EP0906955A2 FtsY |
| 04/07/1999 | EP0906912A1 Indanol derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/07/1999 | EP0906911A1 Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them |
| 04/07/1999 | EP0906910A1 Chromene derivatives and salts thereof, and pharmaceuticals containing the same |
| 04/07/1999 | EP0906909A1 Novel hydroxy and polyhydroxy derivatives of coumarin, peperation thereof and antiviral action thereof |
| 04/07/1999 | EP0906907A1 Compounds potentiating retinoid |
| 04/07/1999 | EP0906761A2 Method of preparing and using phytochemicals |
| 04/07/1999 | EP0906759A1 Novel osteoblastic specific mitogenes: process for their preparation and drugs containing these compounds |
| 04/07/1999 | EP0906758A1 Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents |
| 04/07/1999 | EP0906757A2 Analgesic composition comprising moxonidine and an opioid analgesic agent |
| 04/07/1999 | EP0906756A1 Anti-hiv composition containing imidazole derivative |
| 04/07/1999 | EP0906755A2 Use of phenyl oxazole or phenyl thiazole derivatives for treating neuropathic pain |
| 04/07/1999 | EP0906754A1 Rapid-release s1452 tablets |
| 04/07/1999 | EP0906753A1 Effervescent preparation and process for producing the same |
| 04/07/1999 | EP0906752A1 Use of a plant extract of the Rosaceae family |
| 04/07/1999 | EP0906724A1 Pseudoplastic film-forming acidic chlorite composition as teat dip |
| 04/07/1999 | EP0906441A1 Antitumour cellular compositions expressing at least three transgenes |
| 04/07/1999 | EP0906433A1 Protein tyrosine phosphatases of hematopoietic cells |
| 04/07/1999 | EP0906428A1 Use of interleukin-10 to produce a population of suppressor cells |
| 04/07/1999 | EP0906426A1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 04/07/1999 | EP0906424A2 Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr] |
| 04/07/1999 | EP0906423A1 Metastasis-associated antigen and antibodies thereto |
| 04/07/1999 | EP0906422A1 Human cell death-associated protein |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906419A2 Peptide ligands of the urokinase receptor |
| 04/07/1999 | EP0906416A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them |
| 04/07/1999 | EP0906340A1 Purification of factor viii complex by immunoaffinity chromatography |
| 04/07/1999 | EP0906338A1 Glucagon-like peptide-2 analogs |
| 04/07/1999 | EP0906335A1 Ebv ctl epitopes |
| 04/07/1999 | EP0906332A1 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS |
| 04/07/1999 | EP0906331A1 Cytostatic sterols |
| 04/07/1999 | EP0906330A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE |
| 04/07/1999 | EP0906328A1 Methods and compounds for curing diseases caused by mutations |
| 04/07/1999 | EP0906326A1 Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 04/07/1999 | EP0906325A1 Dendrimers based on saccharides |
| 04/07/1999 | EP0906324A1 Carbohydrate derivatives and their solid-phase synthesis |
| 04/07/1999 | EP0906317A1 Novel water-soluble c-ring analogues of 20(s)-camptothecin |
| 04/07/1999 | EP0906316A1 Novel water-soluble analogues of 20(s)-camptothecin |
| 04/07/1999 | EP0906315A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 04/07/1999 | EP0906313A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/07/1999 | EP0906310A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 04/07/1999 | EP0906309A1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 04/07/1999 | EP0906307A1 Substituted imidazoles having cytokine inhibitory activity |
| 04/07/1999 | EP0906305A1 1-(1h-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor |
| 04/07/1999 | EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/07/1999 | EP0906301A1 Benzofuryl derivatives and their use |
| 04/07/1999 | EP0906297A1 1,2,4-benzothiadiazine derivatives, their preparation and use |
| 04/07/1999 | EP0906296A1 Process for the preparation of chiral keto-heterocycles of basic amino acids |
| 04/07/1999 | EP0906295A1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents |
| 04/07/1999 | EP0906294A1 Benzoxazinone dopamine d4 receptor antagonists |
| 04/07/1999 | EP0906288A1 New compounds |
| 04/07/1999 | EP0906286A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick |
| 04/07/1999 | EP0906284A1 Tricyclic amine derivatives |
| 04/07/1999 | EP0906283A1 Substituted benzamide derivatives and their use as anticonvulsants |
| 04/07/1999 | EP0906282A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 04/07/1999 | EP0906279A1 Novel pyrrole derivatives |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |
| 04/07/1999 | EP0906273A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 04/07/1999 | EP0906272A2 Peptides |
| 04/07/1999 | EP0906268A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 04/07/1999 | EP0906262A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 04/07/1999 | EP0906127A1 Novel devices for transdermal administering of trimegestone |
| 04/07/1999 | EP0906123A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 04/07/1999 | EP0906122A2 Activated linkers and methods for making and purifying the same |
| 04/07/1999 | EP0906121A1 Vasoactive effects and free radical generation by beta-amyloid peptides |
| 04/07/1999 | EP0906120A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide |
| 04/07/1999 | EP0906118A1 Method for treating inflammation |
| 04/07/1999 | EP0906117A1 Method for treating or preventing ischemia-reperfusion injury |
| 04/07/1999 | EP0906114A2 Antipsoriatic compositions, method of making, and method of using |
| 04/07/1999 | EP0906112A2 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
| 04/07/1999 | EP0906111A1 Composition and method for treating herpes simplex |
| 04/07/1999 | EP0906110A1 Dna vaccine formulations |